
Jyong Biotech
(NASDAQ) MENS
Jyong Biotech Financials at a Glance
Market Cap
$121.74M
Revenue (TTM)
$0.00
Net Income (TTM)
-$4.67M
EPS (TTM)
-$0.06
P/E Ratio
-25.83
Dividend
$0.00
Beta (Volatility)
5.29 (High)
Dividend
$0.00
Beta (Volatility)
5.29 (High)
Price
$1.63
Volume
110
Open
$1.58
Price
$1.63
Volume
110
Open
$1.58
Previous Close
$1.64
Daily Range
$1.58 - $1.67
52-Week Range
$1.43 - $67.00
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
5.29 (High)
Price
$1.63
Volume
110
Open
$1.58
Previous Close
$1.64
Daily Range
$1.58 - $1.67
52-Week Range
$1.43 - $67.00
Estimated Earnings Date
N/A
MENS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jyong Biotech
Industry
Biotechnology
Sector
Health CareEmployees
27
CEO
Fu-Feng Kuo, MBA
Headquarters
New Taipei City, 221, TW
MENS Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
19.72%
Return on Capital
N/A
Return on Assets
-22.48%
Earnings Yield
-3.87%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$121.74M
Shares Outstanding
74.23M
Volume
110
Avg. Volume
103.01K
Financials (TTM)
Gross Profit
-$58.00K
Operating Income
-$2.61M
EBITDA
-$2.63M
Operating Cash Flow
-$3.62K
Capital Expenditure
$0.00
Free Cash Flow
-$3.62K
Cash & ST Invst.
$1.18M
Total Debt
$18.55M
Jyong Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$121.74M
N/A
Market Cap/Employee
$3.93M
N/A
Employees
31
N/A
Net Income
-$3.42M
-515586.3%
EBITDA
-$1.79M
-402824.6%
Quarterly Fundamentals
Total Cash
$1.18M
+1127.1%
Total Debt
$18.55M
+6.8%
Accounts Receivable
$13.51M
N/A
Inventory
$0.00
N/A
Long Term Debt
$10.19M
+4.5%
Short Term Debt
$8.36M
+9.7%
Return on Assets
-22.48%
N/A
Return on Invested Capital
18.58%
N/A
Free Cash Flow
-$425.50
+35.0%
Operating Cash Flow
-$425.50
+35.0%